Short Interest in ConvaTec Group PLC (OTCMKTS:CNVVY) Declines By 83.8%

ConvaTec Group PLC (OTCMKTS:CNVVY) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 455 shares, a decline of 83.8% from the April 15th total of 2,801 shares. Based on an average trading volume of 31,619 shares, the short-interest ratio is currently 0.0 days.

ConvaTec Group Price Performance

OTCMKTS:CNVVY traded down $0.08 during mid-day trading on Thursday, hitting $11.12. 58,168 shares of the stock traded hands, compared to its average volume of 75,991. The business’s 50-day moving average price is $12.09 and its 200 day moving average price is $12.48. ConvaTec Group has a 12-month low of $10.95 and a 12-month high of $16.65.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised shares of ConvaTec Group to a “strong-buy” rating in a research report on Wednesday, January 28th. Two analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, ConvaTec Group currently has an average rating of “Strong Buy”.

About ConvaTec Group

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.